Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Qidong CaiBoxue HePengfei ZhangZhenyu ZhaoXiong PengYuqian ZhangHui XieXiang WangPublished in: Journal of translational medicine (2020)
In summary, our study provides insight into LUAD researches and managements based on these AS biomarkers.
Keyphrases